Nomad Power Solutions (NMAD) vs Tenax Therapeutics (TENX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Nomad Power Solutions (NMAD) has outperformed Tenax Therapeutics (TENX) over the past year, losing 11.2% versus a loss of 76.2%. Over five years, NMAD leads with a -77.2% price change compared with -99.9% for TENX. Tenax Therapeutics is the larger company by market cap ($69.6 million vs $68.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NMAD | TENX |
|---|---|---|
| Share price | $4.27 | $1.86 |
| Market cap | $68.75M | $69.61M |
| 1-day change | +0.47% | -2.62% |
| YTD return | +8.65% | -84.74% |
| 1-year return | -11.23% | -76.25% |
| 5-year return | -77.17% | -99.93% |
| EPS (TTM) | $-1.01 | $-1.48 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.38 | $19.40 |
| 52-week low | $2.36 | $1.31 |
| Distance from 52-week high | -49.05% | -90.41% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +575.27% |
| Average volume | 277.61K | 5.46M |
| Shares outstanding | 16.10M | 37.42M |
| Employees | — | 14 |
| Sector | Industrials | Healthcare |
| Industry | Electrical Equipment & Parts | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NMAD has outperformed TENX by 65.0 percentage points over the past year.
- The two companies sit in different sectors: Nomad Power Solutions in Industrials and Tenax Therapeutics in Healthcare.
About Nomad Power Solutions
NMAD stock →NOMAD Power Solutions, Inc. develops utility-scale mobile energy storage systems on providing transportable solutions.
Industrials · Electrical Equipment & Parts
About Tenax Therapeutics
TENX stock →Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia.
Healthcare · Biotechnology · 14 employees
NMAD vs TENX FAQ
Which is bigger, Nomad Power Solutions or Tenax Therapeutics?
Tenax Therapeutics (TENX) is larger, with a market capitalization of $69.61M compared with $68.75M for Nomad Power Solutions (NMAD).
Which stock has performed better over the past year, NMAD or TENX?
NMAD returned -11.23% over the past 12 months, compared with -76.25% for TENX (price return, excluding dividends). Past performance does not predict future results.
Are Nomad Power Solutions and Tenax Therapeutics in the same industry?
No. Nomad Power Solutions is in the Industrials sector, while Tenax Therapeutics is in Healthcare.